The China dermal fillers market is expected to grow at the highest CAGR of 8.7% during the forecast period. China’s market has both medium and long-term potential due to its large market size, aging population, and sedentary lifestyle. The Chinese economy is becoming an R&D-intensive economy which is the major factor for the growth of the market in China. Some of the major factors propelling the growth of the market include the increasing disposable personal income and influencing average income coupled with the changing consumer habits in the Chinese population. Along with this, the significant presence of the middle-aged population is another of the prominent factors that drive the growth of the market in China.
The China dermal fillers market can be segmented based on application, type, and end-users. Based on application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other application. Moreover, based on type, the market is segmented into collagen fillers, poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and others. Based on end-users, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development.
There are several companies operating in China dermal fillers market in China include Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Cynosure LLC, Prollenium Medical Technologies, Inc., and Teoxane SA. Bioha Laboratories produces medical sodium hyaluronate gel, having international standard hardware and facilities and European CE & ISO market products. The company offers its products in more than 30 countries. The company’s branded beauty product, Reyoungel, is an HA dermal filler which is a biodegradable gel made of non-animal cross-linked HA. Reyoungel helps in treating facial lines, wrinkles, and lips to create natural-looking results and is used for facial sculpting and body reshaping.
Research Methodology
The market study of the China dermal fillers market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
The report is intended for healthcare companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
1. China Dermal Fillers Market Research and Analysis by Application
2. China Dermal Fillers Market Research and Analysis by Type
3. China Dermal Fillers Market Research and Analysis by End-User
The Report Covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. China Dermal Fillers Market by Application
5.1.1. Face-Lift
5.1.2. Lip Treatment/Enhancement
5.1.3. Facial Line Correction Treatment
5.1.4. Others (Acne Scar Treatment)
5.2. China Dermal Fillers Market by Type
5.2.1. Collagen Fillers
5.2.2. Ploy-L-Lactic Acid (PLLA)
5.2.3. Hyaluronic Acid (HA)
5.2.4. Calcium Hydroxylapatite (CaHA)
5.2.5. Others (Autologous Fat Injections and Polymethylmethacrylate (PMMA))
5.3. China Dermal Fillers Market by End-User
5.3.1. Dermatology Clinics
5.3.2. Hospitals
6. Company Profiles
6.1. Allergan PLC
6.2. BIOHA Laboratories
6.3. BioPlus Co., Ltd.
6.4. Croma-Pharma GmbH
6.5. Cynosure LLC
6.6. Dr. Korman Laboratories Ltd.
6.7. Galderma Laboratories, L.P.
6.8. Huons Co. Ltd.
6.9. Merz Pharmaceuticals GmbH
6.10. Sculpt Luxury Dermal Fillers Ltd.
6.11. Shanghai Bioha Technologies Co., Ltd.
6.12. Sinclair Pharma Ltd.
6.13. Teoxane SA
6.14. Vivacy Laboratories
6.15. Zhejiang Jingjia Medical Technology Co., Ltd.
1. CHINA DERMAL FILLERS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
2. CHINA DERMAL FILLERS MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
3. CHINA DERMAL FILLERS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. CHINA DERMAL FILLERS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
2. CHINA DERMAL FILLERS MARKET SHARE BY TYPE, 2018 VS 2025 (%)
3. CHINA DERMAL FILLERS MARKET SHARE BY END-USER, 2018 VS 2025 (%)